Untitled Document

HEMATOLOGY/ONCOLOGY FELLOWSHIP PROGRAM DIRECTOR AND DIVISION CHIEF

Barbara Conley, MD
Professor of Medicine

Dr. Conley is a 1979 graduate of Michigan State University's College of Human Medicine. She received her medical oncology training from the University of Maryland from 1984 to 1987 and is board certified in medical oncology. She was appointed as Professor of Medicine and Chief of the Hematology/Oncology division in the Department of Medicine in February 20.Prior to her MSU appointment, Dr. Conley was at the National Cancer Institute from 1997 to 2004 where she was a medical officer and senior investigator. From 1997 to 1999, she had oversight of the NCI's cooperative group program in clinical trials for head and neck, lung and gatsrointestinal cancer. From 1999 to 2002 she served as Chief of NCI's Diagnostics Research Branch, where she was able to foster clinical development of molecular markers that could predict either the prognosis of a tumor once diagnosed or it's response to treatment. From 2002 to the present, she was Head, Aerodigestive Cancer Clinical Trials Section in NCI's intramural program, where she focused on translating laboratory findings into early clinical trials. Prior to her NCI appointment, she served for 10 years on the faculty of the University of Maryland Greenebaum Cancer Center, achieving the rank of Associate Professor of Medicine, Oncology and Pharmacology. Dr. Conley's research interests include new drug development, pharmacology/pharmacokinetics, chemiprevention of cancer, and clinical trials involving cancers of the head and neck, lung and gastrointestinal tract.

HEMATOLOGY/ONCOLOGY FELLOWSHIP ASSISTANT PROGRAM DIRECTOR

Anas Al-Janadi, MD
Assistant Professor of Medicine

Dr. Al-Janadi received his MD degree from Damascus University in 1991, completed his residency in 1998 from St. Barnabas Hospital, Cornell Medical Center, Bronx, NY and his fellowship in Hematology and Oncology from Henry Ford Health System, Detroit, MI. Dr. Al-Janadi is board certified in Hematology and Oncology.

FACULTY

Kenneth Schwartz, MD, FACP
Professor of Medicine

Dr. Schwartz completed his medical degree from Temple University in 1970, his internship and residency from Cincinnati General Hospital in 1978, and fellowship training in Hematology from the University of Michigan and Hematology/Oncology from the University of Washington in Seattle. Dr. Schwartz's research interests follow in two broad areas. The first is platelets, platelet function, immunologic reactions of platelets, detecting antibodies associated with platelets, platelets as they relate to cardiovascular disease and pharmacologic inhibition of platelet function. He has designed several novel techniques to measure and quantitative platelet antibodies, as well as to quantitate the effect of aspirin inhibition. Studies of both the antibody assays and aspirin effects on cardiovascular patients are ongoing

Dr. Schwartz's second major focus is in iron and iron overload toxicities. He has a recent publication detailing sudden death in the guinea pig model of iron overload. This has lead to a series of investigations focusing on cardiac effects of iron and effects of iron on cardiac arrhythmias using different animal models. These studies are also funded and ongoing.

Deimante Tamkus, MD
Assistant Professor Medicine

Dr. Tamkus completed her hematology/oncology fellowship at Cook County Hospital in June 2006. She has a special interest in breast cancer and will be developing additional clinical trails for this desease, working with faculty at MSU, with basic scientists and with practitioners in the region.

Fellowship Application		HEMATOLOGY/ONCOLOGY FELLOWSHIP PROGRAM DIRECTOR AND DIVISION CHIEF Barbara Conley, MD Professor of Medicine Dr. Conley is a 1979 graduate of Michigan State University's College of Human Medicine. She received her medical oncology training from the University of Maryland from 1984 to 1987 and is board certified in medical oncology. She was appointed as Professor of Medicine and Chief of the Hematology/Oncology division in the Department of Medicine in February 20.Prior to her MSU appointment, Dr. Conley was at the National Cancer Institute from 1997 to 2004 where she was a medical officer and senior investigator. From 1997 to 1999, she had oversight of the NCI's cooperative group program in clinical trials for head and neck, lung and gatsrointestinal cancer. From 1999 to 2002 she served as Chief of NCI's Diagnostics Research Branch, where she was able to foster clinical development of molecular markers that could predict either the prognosis of a tumor once diagnosed or it's response to treatment. From 2002 to the present, she was Head, Aerodigestive Cancer Clinical Trials Section in NCI's intramural program, where she focused on translating laboratory findings into early clinical trials. Prior to her NCI appointment, she served for 10 years on the faculty of the University of Maryland Greenebaum Cancer Center, achieving the rank of Associate Professor of Medicine, Oncology and Pharmacology. Dr. Conley's research interests include new drug development, pharmacology/pharmacokinetics, chemiprevention of cancer, and clinical trials involving cancers of the head and neck, lung and gastrointestinal tract. HEMATOLOGY/ONCOLOGY FELLOWSHIP ASSISTANT PROGRAM DIRECTOR Anas Al-Janadi, MD Assistant Professor of Medicine Dr. Al-Janadi received his MD degree from Damascus University in 1991, completed his residency in 1998 from St. Barnabas Hospital, Cornell Medical Center, Bronx, NY and his fellowship in Hematology and Oncology from Henry Ford Health System, Detroit, MI. Dr. Al-Janadi is board certified in Hematology and Oncology. FACULTY Kenneth Schwartz, MD, FACP Professor of Medicine Dr. Schwartz completed his medical degree from Temple University in 1970, his internship and residency from Cincinnati General Hospital in 1978, and fellowship training in Hematology from the University of Michigan and Hematology/Oncology from the University of Washington in Seattle. Dr. Schwartz's research interests follow in two broad areas. The first is platelets, platelet function, immunologic reactions of platelets, detecting antibodies associated with platelets, platelets as they relate to cardiovascular disease and pharmacologic inhibition of platelet function. He has designed several novel techniques to measure and quantitative platelet antibodies, as well as to quantitate the effect of aspirin inhibition. Studies of both the antibody assays and aspirin effects on cardiovascular patients are ongoing Dr. Schwartz's second major focus is in iron and iron overload toxicities. He has a recent publication detailing sudden death in the guinea pig model of iron overload. This has lead to a series of investigations focusing on cardiac effects of iron and effects of iron on cardiac arrhythmias using different animal models. These studies are also funded and ongoing. Deimante Tamkus, MD Assistant Professor Medicine Dr. Tamkus completed her hematology/oncology fellowship at Cook County Hospital in June 2006. She has a special interest in breast cancer and will be developing additional clinical trails for this desease, working with faculty at MSU, with basic scientists and with practitioners in the region. Sunil Nagpal, MD Assistant Professor of Medicine, Dr. Nagpal received his MD degree from Maulana Azad Medical College, New Delhi, India in 1990 and is a 2008 graduate from the MSU Hematology/Oncology Felowship program. He is board certified in Internal Medicine and Hematology and Medical Oncology. Madan Arora, MD Assistant Professor of Medicine Dr. Arora received his medical degree from the Dayanand Medical College in India and a fellowship in hematology/oncology at Wayne State University in Detroit, Michigan. Following is fellowship in 1981, Dr. Arora then completed a research fellowship in hypertension and nephrology at Henry Ford Hospital. Dr. Arora is currently on staff at McLaren Regional Medical Center. MSU Hematology/Oncology subspecialty residents do monthly rotations at Dr. Arora's practice in Flint, Michigan. Nikolay Dimitrov, M.D. Professor Emeritus Dr. Dimitrov completed his medical degree at the Medical Academy in Sofia, Bulgaria. His research interests include breast cancer and cancer prevention. 2009-2010 - YEAR III Fellows SREENIVASA CHANDANA, MD SHALINI CHITNENI , MD 2009-2010 - YEAR II FELLOWS VIJAY CHAUDHARY, MD SIMONA CHIVU , MD 2008-2009 - YEAR I FELLOWS SANJA KALUZA, MD SARAH ALI, MD SUPPORT STAFF HEMATOLOGY/ONCOLOGY FELLOWSHIP PROGRAM COORDINATOR BECKY MCMAHON, MA Ms. McMahon received her master's degree in education from West Virginia University in 1975 and has worked in the College of Human Medicine for over 34 years. Prior to joining the hematology/oncology fellowship in 2000, she was program coordinator for the gastroenterology fellowship. Ms. McMahon brings to the program her many years of experience in faculty credentialing, recruitment and knowledge of the day to day operations of the University.
Educational Goals & Objectives
Rotation Schedules
Forms
LINKS BELOW
MSU Medical Graduate Education Manual
American Board of Internal Medicine
ACGME
HOME